Thyroid function and autoimmunity in Parkinson's disease: A study of 101 patients

Parkinsonism and Related Disorders

Volumn 5, Issue 1-2, 1999, Pages 49-53

  Bonuccelli, U ^a   D'Avino, C ^a   Caraccio, N ^b   Del Guerra, P ^b   Casolaro, A ^b   Pavese, N ^a   Del Dotto, P ^a   Monzani, F ^b  

^a Department of Neuroscience   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Autoimmune thyroid diseases; Parkinson's disease; Thyroid hormones

Indexed keywords

LEVODOPA; THYROID HORMONE;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DEIODINATION; DISEASE ASSOCIATION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC CLEARANCE RATE; PARKINSON DISEASE; PRIORITY JOURNAL; THYROID DISEASE; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROID NODULE;

EID: 0033029980     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(99)00010-3     Document Type: Article

References (33)

1. Berger J.R., Kelly R.E. Thyroid function in Parkinson's disease. Neurology. 31:1981;93-95.
2. Verges B., Giroud M., Richard A., et al. Parkinson's disease after antithyroid treatment (letter). Lancet. 2:1988;564.
3. Verges B., Giroud M., Vaillant G., Verges-Patois B., Brun J.M., Putelat R. Ultrasensitive TSH assay and anti-PD patients treatment with L-dopa (letter). J. Neurol. Neurosurg. Psyc. 59:1992;1210-1211.
4. Lavy S., Marks E.S., Abramsky O. Parkinsonism and hyperthyroidism. Eur. Neurol. 12:1974;20-27.
5. Cooper D.S., Klibanski A., Ridgway E.C. Dopaminergic modulation of TSH and its subunits: in vivo and in vitro studies. Clin. Endocrinol. 18:1983;265-275.
6. Besses G.S., Burrow G.N., Spaulding S.W., Donabedian R.K. Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. J. Clin. Endocrinol. Metab. 41:1975;985-988.
7. Spaulding S.W., Burrow G.N., Donabedian R.K., et al. L-dopa suppression of thyropin releasing hormone response in man. J. Clin. Endocrinol. Metab. 35:1972;182-185.
8. Boyd A.E. III, Lebowitz H.E, Feldman J.M. Endocrine function and glucose metabolism in patients with Parkinson's disease and their alteration by L-dopa. J. Clin.Endocr. 33:1971;829-837.
9. Wingert T.D., Herschmann J.M. Sinemet and thyroid function in Parkinson disease. Neurology. 29:1979;1073-1074.
10. Lestingi L., Bonifati V., Stocchi F., Antonozzi I., Meco G. TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease. Eur. Neurol. 32:1992;65-69.
11. Martignoni E., Horowski R., Liuzzi A., Costa A., Dallabonzana D., Cozzi R., Attanasio R., Rainer E., Nappi G. Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo. Clin. Neuropharmacol. 19:1996;72-80.
12. Caradoc-Davies T.H. Resolution of dyskinesia and the "on-off" phenomenon in thyreotoxic patients with Parkinson's disease after antithyroid treatment. Br. Med. J. 293:1986;38-39.
13. McRae-Deguerce A., Gottfries C.G., Karlsson I., Svennerholm I., Dahlström A. Antibodies in the CSF of a Parkinson patient recognize neurons in rat mesencephalic regions. Acta Physiol. Scand. 126:1986;313-315.
14. McRae-Deguerce A., Klawans H.L., Penn R.D., Dahlström A., Tonner C.M., Goetz C.G., Carvey P.M. An antibody in the CSF of a Parkinson disease patients disappears following adrenal medulla transplantation. Neurosci. Lett. 94:1988;192-197.
15. Fiszer U., Mix E., Fredrikson S., Kostulas V., Olsson T., Link H. Gamma delta +T cells are increased in patients with Parkinson's disease. J. Neurol. Sci. 121:1994;39-45.
16. Kunas R.C., McRae A., Kesserling J., Villinger P.M. Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's disease. J. Allergy Clin. Immunol. 96:1995;688-690.
17. Le W.D., Engelhardt J., Xie W.J., Schneider L., Smith R.G., Appel S.H. Experimental autoimmune nigral damage in guinea pigs. J. Neuroimmunol. 57:1995;45-53.
18. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology. 17:1967;427-442.
19. Fahn S., Elton R.L. Unified Parkinson's disease rating scale. Fahn S., Marsden C.D., Calne D.B., Goldstein M. Recent developments in Parkinson's disease. 2 :1987;153-163 Macmillan Health Care Information, New York.
20. Ross D.S. Subclinical hypothyroidsm. Braverman L.E., Utiger R.D. Werner and Ingbar's The thyroid. 6 :1991;1256-1262 J.B. Lippincott, Philadelphia, New York, London.
21. Martilla R.J., Eskola J., Päivärinta M., Rinne U.K. Immune functions in Parkinson's disease. Adv. Neurol. 40:1984;315-323.
22. Martilla R.J., Eskola J., Soppi E., Rinne U.K. Immune functions in Parkinson's disease lymphocyte subsets, concanavalin A-induced suppressor cell activity and in vitro immunoglobulin production. J. Neurol. Sci. 69:1985;121-131.
23. Hawkins B.R., Cheah P.S., Dawwkins R.L., et al. Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet. 2:1980;1057.
24. Mariotti S., Santoni P., Barbesino G., et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet. 339:1992;1506.
25. Lazarus J.H., Burr M.L., McGregor A.M., et al. The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol. 106:1984;199-202.
26. Vanderpump M.P.J., Tunbridge W.M.G. The epidemiology of Thyroid Diseases. Braverman L.E., Utiger R.D. Werner and Ingbar's The thyroid. 7 :1996;474-482 Lippincott-Raven, Philadelphia, New York.
27. Tunbridge W.M.G., Caldwell G. The epidemiology of thyroid diseases. Braverman L.E., Utiger R.D. Werner and Ingbar's The thyroid. 6 :1991;578-587 J.B. Lippincott, Philadelphia, New York, London.
28. Samuels M.H., Veldhuis J.D., Henry P., Ridgway E.C. Pathophysiology of pulsatile and copulsatile release of thyroid-stimulating hormone, luteinizing hormone, follicle-stimulating hormone and α subunit. J. Clin. Endocrinol. Metab. 71:1990;425-432.
29. Steventon G.B., Heafield M.T.E., Waring R.H., Williams A.C. Xenobiotic metabolism in Parkinson's disease. Neurology. 39:1989;883-887.
30. Kohrle J., Hesch R.D., Leonard J.L. Intracellular pathways of iodothyronine metabolism. Braverman L.E., Utiger R.D. Werner and Ingbar's The thyroid. 6 :1991;144-189 J.B. Lippincott, Philadelphia, New York, London.
31. Cooper D.S. Subclinical hypothyroidism. Jama. 258:1987;246-247.
32. Evered D.C., Clark F., Petersen V.B. Thyroid function in euthyroid subjects with autonomous thyroid nodules. Clin. Endocrinol. (Oxf). 3:1974;149-154.
33. Studer H., Ramelli F. Simple goiter and its variants: euthyroid and hyperthyroid multinodular goiters. Endocr. Rev. 3:1982;40-61.